aripiprazole has been researched along with Central Hypothyroidism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, K; Inoue, S; Ohta, H; Watanabe, A | 1 |
| Goldman, J; Kanzali, P; Paras, C; Rubin, V; Zhang, F | 1 |
| Aderhold, V; Haasen, C; Lambert, M; Reimer, J | 1 |
3 other study(ies) available for aripiprazole and Central Hypothyroidism
| Article | Year |
|---|---|
TSH and PRL, side-effect markers in aripiprazole treatment: adjunctive aripiprazole-induced thyrotropin oversuppression in a young man with schizophrenia.
Topics: Adult; Aripiprazole; Biomarkers; Diagnosis, Differential; Humans; Hypothyroidism; Male; Prolactin-Releasing Hormone; Schizophrenia, Paranoid; Thyrotropin | 2017 |
Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Chlorpromazine; Creatine Kinase; Diagnosis, Differential; Drug Substitution; Fluid Therapy; Humans; Hypothyroidism; Male; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid; Thyroid Nodule; Thyrotropin; Treatment Outcome | 2017 |
Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Diet; Epilepsy, Generalized; Female; Hallucinations; Humans; Hypnotics and Sedatives; Hypothyroidism; Lorazepam; Magnetic Resonance Imaging; Multiple Sclerosis; Paranoid Disorders; Piperazines; Psychotic Disorders; Quinolones | 2006 |